Pinilla L, Tena-Sempere M, Gonzalez D, Aguilar E
Department of Physiology, Faculty of Medicine, Córdoba University, Spain.
J Endocrinol Invest. 1999 May;22(5):340-8. doi: 10.1007/BF03343571.
The gaseous transmitter nitric oxide (NO) appears to be involved in the control of LH secretion and in the modulation of LH responses after stimulation with luteinizing hormone releasing hormone (LHRH), excitatory amino acids (EAAs) and leptin. The regulatory action of NO in the control of LH secretion includes modulation of LHRH release, changes in hypothalamic-pituitary blood flow and direct effects at pituitary level. To determine the net balance of these actions we evaluated (1) the effects of systemic administration of sodium nitroprusside (SNP, a NO donor) and Nw-nitro-L-arginine methyl ester (NAME, a blocker of NO synthase) on basal and LHRH-stimulated LH secretion in intact and ovariectomized females; and (2) the effects of SNP and NAME on LH secreted by dispersed pituitary cells. Finally, since NO is involved in the stimulatory effect of excitatory amino acids (EAAs) on LH secretion, we analyzed the effects of different inhibitors of NO synthase (NOS) in the LH response to kainic acid (KA), an agonist of kainate receptors, in male and female rats, neonatally injected with estradiol that show an increased sensitivity to EAAs. We found that NAME (40 and 60 mg/kg) increases LH secretion in intact and ovariectomized females, while SNP had no effect. The effect of NAME was not mediated through a direct action at pituitary level, since the basal and LHRH-stimulated LH release remained unchanged in presence of NAME. Similarly, basal and LHRH-stimulated LH secretion from dispersed pituitary cells were unaffected by NAME. Finally, the stimulatory effects of KA on LH release were not abolished by NOS inhibitors. In conclusion, our results provide evidence that the global action of NOS inhibitors is an increase in basal LH secretion, through a mechanism that remains to be fully characterized. In addition, our data demonstrate that the KA-stimulated LH secretion is not mediated by an increase in NO generation.
气态递质一氧化氮(NO)似乎参与促黄体生成素(LH)分泌的调控以及在促黄体生成素释放激素(LHRH)、兴奋性氨基酸(EAA)和瘦素刺激后对LH反应的调节。NO在LH分泌调控中的调节作用包括调节LHRH释放、下丘脑 - 垂体血流变化以及在垂体水平的直接作用。为了确定这些作用的净平衡,我们评估了:(1)硝普钠(SNP,一种NO供体)和Nω-硝基-L-精氨酸甲酯(NAME,一种NO合酶抑制剂)全身给药对完整和去卵巢雌性动物基础和LHRH刺激的LH分泌的影响;以及(2)SNP和NAME对分散垂体细胞分泌的LH的影响。最后,由于NO参与兴奋性氨基酸(EAA)对LH分泌的刺激作用,我们分析了不同的NO合酶(NOS)抑制剂对新生注射雌二醇的雄性和雌性大鼠中对红藻氨酸(KA,一种红藻氨酸受体激动剂)刺激的LH反应的影响,这些大鼠对EAA表现出更高的敏感性。我们发现NAME(40和60mg/kg)增加完整和去卵巢雌性动物的LH分泌,而SNP没有作用。NAME的作用不是通过在垂体水平的直接作用介导的,因为在NAME存在下基础和LHRH刺激的LH释放保持不变。同样,分散垂体细胞的基础和LHRH刺激的LH分泌不受NAME影响。最后,KA对LH释放的刺激作用未被NOS抑制剂消除。总之,我们的结果提供了证据,表明NOS抑制剂的总体作用是通过一种仍有待充分表征的机制增加基础LH分泌。此外,我们的数据表明KA刺激的LH分泌不是由NO生成增加介导的。